Holen Sie sich die Stockscreener-App
6.11
4.62%
0.27
Handel nachbörslich:
6.11
Schlusskurs vom Vortag:
$5.84
Offen:
$5.94
24-Stunden-Volumen:
22,026
Relative Volume:
1.84
Marktkapitalisierung:
$9.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-5.2672
EPS:
-1.16
Netto-Cashflow:
$-28.71M
1W Leistung:
+13.15%
1M Leistung:
+29.18%
6M Leistung:
-59.33%
1J Leistung:
-45.57%
1-Tages-Spanne:
$5.66
$6.31
1-Wochen-Bereich:
$5.2199
$6.31
52-Wochen-Spanne:
$4.11
$21.25
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| FBRX | 6.11 | 9.02M | 0 | -31.48M | -28.71M | -1.16 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Forte Biosciences (NASDAQ:FBRX) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World
Forte Biosciences Inc reports results for the quarter ended September 30Earnings Summary - XM
Perceptive Advisors LLC Acquires Shares in Forte Biosciences Inc - GuruFocus.com
Forte Biosciences Inc (FBRX) Quarterly 10-Q Report - Quartzy
Forte Biosciences Inc. Reports Q3 2024 Earnings - TipRanks
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Forte Biosciences Advances Celiac Disease Trial as Q3 Losses Widen to $4.54/Share | FBRX Stock News - StockTitan
Head to Head Analysis: Sycamore Entertainment Group (OTCMKTS:SEGI) & Forte Biosciences (NASDAQ:FBRX) - Defense World
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World
Traders Buy Large Volume of Call Options on Alaska Air Group (NYSE:ALK) - Defense World
Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) - Defense World
Wendy’s Target of Unusually High Options Trading (NASDAQ:WEN) - Defense World
Traders Buy High Volume of Call Options on Guidewire Software (NYSE:GWRE) - Defense World
Patterson-UTI Energy Sees Unusually Large Options Volume (NASDAQ:PTEN) - Defense World
SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA) - Defense World
Stock Traders Buy Large Volume of Call Options on Etsy (NASDAQ:ETSY) - Defense World
Sunnova Energy International Target of Unusually High Options Trading (NYSE:NOVA) - Defense World
FBRX stock touches 52-week low at $4.41 amid market challenges - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days - Mugglehead
CSG Forte Engage Honored for Innovation in Top Industry Awards - Yahoo Finance
Organic Propolis Market Report Analysis, Research Studies |Forté Pharma, Propolia, HoneyGreen, Parchem, Bee Health, Vond – IndiaPolitics.com - IndiaPolitics.com
FBRX stock touches 52-week low at $4.8 amid market challenges - Investing.com Australia
FBRX stock touches 52-week low at $4.8 amid market challenges By Investing.com - Investing.com South Africa
(FBRX) Investment Analysis and Advice - Stock Traders Daily
"Forte Opening Solutions" Brand Replaces "Masonite Architectural" While Renewing Commitment to Commercial Customers - Yahoo Finance
FBRX stock touches 52-week low at $4.81 amid market challenges - Investing.com India
United States shares lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Luxury Hotelier Sir Rocco Forte Is Focused on Leaving a Legacy Behind - Yahoo Finance
Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Forte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX) - Defense World
When the Price of (FBRX) Talks, People Listen - Stock Traders Daily
FBRX stock touches 52-week low at $6.47 amid market challenges - Investing.com
Forte Biosciences reshuffles board, settles lawsuit - Investing.com India
Forte Biosciences reshuffles board, settles lawsuit By Investing.com - Investing.com Australia
Forte Biosciences Welcomes New Directors Amidst Strategic Changes - TipRanks
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
(FBRX) Long Term Investment Analysis - Stock Traders Daily
FBRX stock touches 52-week low at $6.9 amid market challenges - Investing.com
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Trading 5.9% Higher - Defense World
FORTE BIOSCIENCES INC. Trade Ideas — MUN:37T - TradingView
Forte Biosciences executes reverse stock split - Investing.com
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short Interest - MarketBeat
FBRX stock touches 52-week high at $8.62 amid market fluctuations - Investing.com Canada
Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested - Yahoo Finance
Upcoming Stock Splits This Week (August 26 to August 30) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
Forte Biosciences announces stockholder-approved equity plan By Investing.com - Investing.com Australia
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):